DomaniCell, LLC (DomaniCell), a leading service provider in the field of stem cell collection and storage, announced today it has obtained a license to perform umbilical cord blood collection, processing, and storage from the New Jersey Department of Health and Senior Services.
DomaniCell is applying for similar licenses, where required, in States throughout the country as it launches its hospital-based family cord blood collection and storage service.
In addition to state-level licensure, DomaniCell’s licensed program also includes a nationwide license from PharmaStem Therapeutics, Inc. to PharmaStem's patent portfolio for the storage and use of umbilical cord blood. The nature of DomaniCell's license is exclusive and thus provides hospitals with unique protection from patent-infringement claims.
“Our license strategy allows DomaniCell to enter into relationships with hospital partners to develop their own cord blood stem cell banking program that is built on DomaniCell infrastructure and technology,” states DomaniCell President Dennis Fallen. “The response we have received to-date from discussions with hospitals across the country has been overwhelmingly positive.”
About DomaniCell LLC
DomaniCell LLC is a wholly owned subsidiary of Progenitor Cell Therapy LLC. Launched in 2006, DomaniCell is a national pioneer in the field of stem cell collection and storage, providing innovative family cord blood banking services through hospital partner programs across the country. DomaniCell's family cord blood service brings to hospital clients a unique turn-key solution which results in a hospital private-branded cord blood program establishing an obstetrical service that generates a new source of revenue. For more information on DomaniCell and the advantages of its turnkey hospital-based cord blood banking solution, visit www.domanicell.com.
Contacts:
Dennis Fallen, President, DomaniCell LLC (201) 883-5308. dfallen@domanicell.com
